Daryl Grummitt Email

VP New Product Development . Owl biomedical

Current Roles

Employees:
18
Revenue:
$4.5M
About
A company founded to advance MEMS as a sterile, live-cell sorting platform for cell therapy and cancer diagnostics. Owl biomedical, Inc. is owned by Miltenyi Biotec GmbH, a world leader in cell isolation for therapeutics and innovative research. The Owl biomedical MEMS sorting chip is at the heart of Miltenyi's flagship product, the MACSQuant Tyto. It is truly a revolution in sorting brought about by its inherent gentleness, sterility, and unparalleled ease-of-use.
Owl biomedical Address
75 Robin Hill Rd.
Goleta, CA
United States
Owl biomedical Email

Past Companies

Owl biomedical, Inc.Vice President Of New Product Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.